Charming Medical Limited Class A Ordinary Shares

NASDAQ:MCTA

Medical - Care Facilities

Healthcare
$29.36 +0.00%

+$0.00 today

Market cap
$445.55M
Beta
0.00
P/E (TTM)
414.6
EPS (TTM)
$0.07
52W Low $4.30High $31.70

Volume 0.00M

Average 0.87M

MCTA Gross Margin

Gross profit as a percentage of revenue, showing how much of each sales dollar is kept after direct costs.

Charming Medical Limited Class A Ordinary SharesNASDAQ: MCTA

Gross Margin · FY2024 · year ended Mar 2025

Gross margin widens to 67.2%

Gross margin was 67.2% in FY2024, up 2.1 pp from a year earlier.

Context

  • Gross margin widened in 2 of the last 2 fiscal years.
  • FY2024 was the highest level in the 3 fiscal years shown.

Sources:Income StatementText generated from reported figures; not investment advice.

Last fiscal yearMar 2025
67.2%+2.1 pp YoY
Gross Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter———
1 year+2.1 pp——
3 years———
5 years——
10 years——

Gross Margin history

Percent of revenue · from the income statement

Latest · FY2024
67.2%
Year-over-year change
+2.1pp

Gross Margin vs competitors

How MCTA compares with its peers on the latest reported figures

  • MCTA's FY2024 gross margin of 67.2% is the 4th highest of the 9 companies compared; the peer median is 40.9%.
  • Its year-over-year change of +2.1 pp is the 3rd highest of 9, against a peer median of +0.6 pp.
MCTA Competitors Peer median
Gross Margin for MCTA and competitors
Company Period LTM level YoY 3-year change
DCTHDelcath Systems, Inc.LTM Mar 202686.0% +1.1 pp+11.4 pp
RXSTRxSight, Inc.LTM Mar 202677.0% +9.7 pp+33.1 pp
TCMDTactile Systems Technology, Inc.LTM Mar 202675.7% +1.3 pp+3.9 pp
MCTACharming Medical Limited Class A Ordinary SharesFY202467.2% +2.1 pp—
SLPSimulations Plus, Inc.LTM Feb 202662.0% +6.7 pp-21.5 pp
CCRNCross Country Healthcare, Inc.LTM Mar 202619.8% -0.5 pp-3.6 pp
TOIThe Oncology Institute, Inc.LTM Mar 202614.8% +0.1 pp-5.4 pp
AGLAgilon Health, Inc.LTM Mar 2026-2.7% -2.4 pp-7.8 pp
NAKANakamoto Inc.LTM Mar 2026-376.0% -309.7 pp-604.8 pp
ANNXAnnexon, Inc.FY2025— ——
Peer median (excluding MCTA) 40.9%+0.6 pp-4.5 pp

Competitors are the stored peer set for MCTA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2022
Mar 2023
FY2023
Mar 2024
FY2024
Mar 2025
Revenue3.53M6.02M6.22M
Cost of Revenue2.04M2.1M2.04M
Gross Profit1.49M3.91M4.18M
Gross Margin42.3%65.1%67.2%
Research & Development000
Selling, General & Admin1.66M2.35M2.32M
Operating Expenses2.02M2.91M2.79M
Depreciation & Amortization211.08K391.7K263.45K
EBITDA(189.13K)1.42M1.72M
EBITDA Margin-5.4%23.6%27.6%
Operating Income(521.34K)1.01M1.39M
Operating Margin-14.8%16.8%22.3%
Interest Income10.29K19.51K64.14K
Interest Expense20.26K26.05K20.87K
Other Income / Expenses100.87K(5.35K)46.23K
Income Before Tax(420.47K)1M1.44M
Pre-Tax Margin-11.9%16.7%23.1%
Income Tax Expense(84.86K)181.75K236.08K
Net Income(305.12K)777.81K1.2M
Net Margin-8.6%12.9%19.3%
EPS (Basic)(0.02)0.050.07
EPS (Diluted)(0.02)0.050.07
Weighted Avg Shares16.94M16.94M16.94M
Weighted Avg Shares (Diluted)16.94M16.94M16.94M

Charming Medical Limited Class A Ordinary Shares

NASDAQ:MCTA

Intrinsic Alpha fair value

Locked

Current Price

$29.36

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.